(1)
Kumdee, C.; Yadee, J.; Pantumongkol, W.; Hadnorntun, P.; Kittiratchakul, N.; Leelahavarong, P.; Suchonwanich, N.; Ekakkararungroj, C. Consequences and Enablers of the Selection of High-Cost Medicines to the National List of Essential Medicines Category E(2). J Health Syst Res 2021, 15, 456-476.